Cytotoxic Drugs Market 2027 By Drug Type, Route of Administration, Distribution Channel and Geopgraphy | The Insight Partners

Cytotoxic Drugs Market to 2027 - Global Analysis and Forecasts by Drug Type (Alkylating Agents, Antitumor Antibiotics, Antimetabolites, Plant Alkaloids, Others ); Route of Administration (Intravenous, Oral ); Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies ) and Geopgraphy

Report Code: TIPRE00006434 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Cytotoxic drugs are used for the destruction of tumors, reduce the metastasis of cancer and alleviate cancer symptoms. These drugs also helps to improve the outcomes of surgery. Cytotoxic drugs are effective on all the dividing cells in the body, including the non-cancerous cells, however this effect is less pronounced and healthy cells are recovered faster.

MARKET DYNAMICS

The cytotoxic drugs market is anticipated to grow in the forecast, owing to increasing prevalence of cancer across the globe, development of cutting edge therapeutic modalities by market players, and others. However, risk of cytotoxic drugs to show adverse effects on non-cancerous cells is likely to refrain the growth of the market.

MARKET SCOPE

The "Global Cytotoxic Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of cytotoxic drugs market with detailed market segmentation by drug type, route of administration, distribution channel, and geography. The global cytotoxic drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading cytotoxic drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global cytotoxic drugs market is segmented on the basis of drug type, route of administration, and distribution channel. Based on drug type, the market is segmented as alkylating agents, antitumor antibiotics, antimetabolites, plant alkaloids, and others. Based on route of administration, the market is segmented into intravenous, and oral. On the basis of distribution channel, the global cytotoxic drugs market is segmented into retail pharmacies, hospital pharmacies, and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cytotoxic drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cytotoxic drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting cytotoxic drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cytotoxic drugs market in these regions.


MARKET PLAYERS

The reports cover key developments in the cytotoxic drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from cytotoxic drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for cytotoxic drugs market in the global market. Below mentioned is the list of few companies engaged in the cytotoxic drugs market.

The report also includes the profiles of key cytotoxic drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Merck KGaA
- Celgene
- Eli Lilly and Company
- Sanofi
- Pfizer, Inc.
- GlaxoSmithKline Plc
- Johnson and Johnson Services, Inc.
- Amgen
- F.Hoffmann La-Roche Ltd.
- Lonza
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cytotoxic Drugs Market - By Drug Type
1.3.2 Cytotoxic Drugs Market - By Route of Administration
1.3.3 Cytotoxic Drugs Market - By Distribution Channel
1.3.4 Cytotoxic Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CYTOTOXIC DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CYTOTOXIC DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CYTOTOXIC DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. CYTOTOXIC DRUGS - GLOBAL MARKET OVERVIEW
6.2. CYTOTOXIC DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CYTOTOXIC DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. ALKYLATING AGENTS
7.3.1. Overview
7.3.2. Alkylating Agents Market Forecast and Analysis
7.4. ANTITUMOR ANTIBIOTICS
7.4.1. Overview
7.4.2. Antitumor Antibiotics Market Forecast and Analysis
7.5. ANTIMETABOLITES
7.5.1. Overview
7.5.2. Antimetabolites Market Forecast and Analysis
7.6. PLANT ALKALOIDS
7.6.1. Overview
7.6.2. Plant Alkaloids Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. CYTOTOXIC DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. INTRAVENOUS
8.3.1. Overview
8.3.2. Intravenous Market Forecast and Analysis
8.4. ORAL
8.4.1. Overview
8.4.2. Oral Market Forecast and Analysis
9. CYTOTOXIC DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. RETAIL PHARMACIES
9.3.1. Overview
9.3.2. Retail Pharmacies Market Forecast and Analysis
9.4. HOSPITAL PHARMACIES
9.4.1. Overview
9.4.2. Hospital Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. CYTOTOXIC DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Cytotoxic Drugs Market Overview
10.1.2 North America Cytotoxic Drugs Market Forecasts and Analysis
10.1.3 North America Cytotoxic Drugs Market Forecasts and Analysis - By Drug Type
10.1.4 North America Cytotoxic Drugs Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Cytotoxic Drugs Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Cytotoxic Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Cytotoxic Drugs Market
10.1.6.1.1 United States Cytotoxic Drugs Market by Drug Type
10.1.6.1.2 United States Cytotoxic Drugs Market by Route of Administration
10.1.6.1.3 United States Cytotoxic Drugs Market by Distribution Channel
10.1.6.2 Canada Cytotoxic Drugs Market
10.1.6.2.1 Canada Cytotoxic Drugs Market by Drug Type
10.1.6.2.2 Canada Cytotoxic Drugs Market by Route of Administration
10.1.6.2.3 Canada Cytotoxic Drugs Market by Distribution Channel
10.1.6.3 Mexico Cytotoxic Drugs Market
10.1.6.3.1 Mexico Cytotoxic Drugs Market by Drug Type
10.1.6.3.2 Mexico Cytotoxic Drugs Market by Route of Administration
10.1.6.3.3 Mexico Cytotoxic Drugs Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Cytotoxic Drugs Market Overview
10.2.2 Europe Cytotoxic Drugs Market Forecasts and Analysis
10.2.3 Europe Cytotoxic Drugs Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Cytotoxic Drugs Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Cytotoxic Drugs Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Cytotoxic Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Cytotoxic Drugs Market
10.2.6.1.1 Germany Cytotoxic Drugs Market by Drug Type
10.2.6.1.2 Germany Cytotoxic Drugs Market by Route of Administration
10.2.6.1.3 Germany Cytotoxic Drugs Market by Distribution Channel
10.2.6.2 France Cytotoxic Drugs Market
10.2.6.2.1 France Cytotoxic Drugs Market by Drug Type
10.2.6.2.2 France Cytotoxic Drugs Market by Route of Administration
10.2.6.2.3 France Cytotoxic Drugs Market by Distribution Channel
10.2.6.3 Italy Cytotoxic Drugs Market
10.2.6.3.1 Italy Cytotoxic Drugs Market by Drug Type
10.2.6.3.2 Italy Cytotoxic Drugs Market by Route of Administration
10.2.6.3.3 Italy Cytotoxic Drugs Market by Distribution Channel
10.2.6.4 Spain Cytotoxic Drugs Market
10.2.6.4.1 Spain Cytotoxic Drugs Market by Drug Type
10.2.6.4.2 Spain Cytotoxic Drugs Market by Route of Administration
10.2.6.4.3 Spain Cytotoxic Drugs Market by Distribution Channel
10.2.6.5 United Kingdom Cytotoxic Drugs Market
10.2.6.5.1 United Kingdom Cytotoxic Drugs Market by Drug Type
10.2.6.5.2 United Kingdom Cytotoxic Drugs Market by Route of Administration
10.2.6.5.3 United Kingdom Cytotoxic Drugs Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Cytotoxic Drugs Market Overview
10.3.2 Asia-Pacific Cytotoxic Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Cytotoxic Drugs Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Cytotoxic Drugs Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Cytotoxic Drugs Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Cytotoxic Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Cytotoxic Drugs Market
10.3.6.1.1 Australia Cytotoxic Drugs Market by Drug Type
10.3.6.1.2 Australia Cytotoxic Drugs Market by Route of Administration
10.3.6.1.3 Australia Cytotoxic Drugs Market by Distribution Channel
10.3.6.2 China Cytotoxic Drugs Market
10.3.6.2.1 China Cytotoxic Drugs Market by Drug Type
10.3.6.2.2 China Cytotoxic Drugs Market by Route of Administration
10.3.6.2.3 China Cytotoxic Drugs Market by Distribution Channel
10.3.6.3 India Cytotoxic Drugs Market
10.3.6.3.1 India Cytotoxic Drugs Market by Drug Type
10.3.6.3.2 India Cytotoxic Drugs Market by Route of Administration
10.3.6.3.3 India Cytotoxic Drugs Market by Distribution Channel
10.3.6.4 Japan Cytotoxic Drugs Market
10.3.6.4.1 Japan Cytotoxic Drugs Market by Drug Type
10.3.6.4.2 Japan Cytotoxic Drugs Market by Route of Administration
10.3.6.4.3 Japan Cytotoxic Drugs Market by Distribution Channel
10.3.6.5 South Korea Cytotoxic Drugs Market
10.3.6.5.1 South Korea Cytotoxic Drugs Market by Drug Type
10.3.6.5.2 South Korea Cytotoxic Drugs Market by Route of Administration
10.3.6.5.3 South Korea Cytotoxic Drugs Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Cytotoxic Drugs Market Overview
10.4.2 Middle East and Africa Cytotoxic Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Cytotoxic Drugs Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Cytotoxic Drugs Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Cytotoxic Drugs Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Cytotoxic Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Cytotoxic Drugs Market
10.4.6.1.1 South Africa Cytotoxic Drugs Market by Drug Type
10.4.6.1.2 South Africa Cytotoxic Drugs Market by Route of Administration
10.4.6.1.3 South Africa Cytotoxic Drugs Market by Distribution Channel
10.4.6.2 Saudi Arabia Cytotoxic Drugs Market
10.4.6.2.1 Saudi Arabia Cytotoxic Drugs Market by Drug Type
10.4.6.2.2 Saudi Arabia Cytotoxic Drugs Market by Route of Administration
10.4.6.2.3 Saudi Arabia Cytotoxic Drugs Market by Distribution Channel
10.4.6.3 U.A.E Cytotoxic Drugs Market
10.4.6.3.1 U.A.E Cytotoxic Drugs Market by Drug Type
10.4.6.3.2 U.A.E Cytotoxic Drugs Market by Route of Administration
10.4.6.3.3 U.A.E Cytotoxic Drugs Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Cytotoxic Drugs Market Overview
10.5.2 South and Central America Cytotoxic Drugs Market Forecasts and Analysis
10.5.3 South and Central America Cytotoxic Drugs Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Cytotoxic Drugs Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Cytotoxic Drugs Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Cytotoxic Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Cytotoxic Drugs Market
10.5.6.1.1 Brazil Cytotoxic Drugs Market by Drug Type
10.5.6.1.2 Brazil Cytotoxic Drugs Market by Route of Administration
10.5.6.1.3 Brazil Cytotoxic Drugs Market by Distribution Channel
10.5.6.2 Argentina Cytotoxic Drugs Market
10.5.6.2.1 Argentina Cytotoxic Drugs Market by Drug Type
10.5.6.2.2 Argentina Cytotoxic Drugs Market by Route of Administration
10.5.6.2.3 Argentina Cytotoxic Drugs Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CYTOTOXIC DRUGS MARKET, KEY COMPANY PROFILES
12.1. MERCK KGAA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CELGENE
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ELI LILLY AND COMPANY
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SANOFI
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PFIZER, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GLAXOSMITHKLINE PLC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JOHNSON AND JOHNSON SERVICES, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. AMGEN
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. F.HOFFMANN LA-ROCHE LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. LONZA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Merck KGaA
2. Celgene
3. Eli Lilly and Company
4. Sanofi
5. Pfizer, Inc.
6. GlaxoSmithKline Plc
7. Johnson and Johnson Services, Inc.
8. Amgen
9. F.Hoffmann La-Roche Ltd.
10. Lonza